Literature DB >> 18989275

Healing hemangiomas.

Lena Claesson-Welsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989275     DOI: 10.1038/nm1108-1147

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.

Authors:  Shoshana Greenberger; Elisa Boscolo; Irit Adini; John B Mulliken; Joyce Bischoff
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

2.  A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.

Authors:  Yang Shen; Lin Zeng; Ruslan Novosyadlyy; Amelie Forest; Aiping Zhu; Andrew Korytko; Haifan Zhang; Scott W Eastman; Michael Topper; Sagit Hindi; Nicole Covino; Kris Persaud; Yun Kang; Douglas Burtrum; David Surguladze; Marie Prewett; Sudhakar Chintharlapalli; Victor J Wroblewski; Juqun Shen; Paul Balderes; Zhenping Zhu; Marshall Snavely; Dale L Ludwig
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.

Authors:  Su Jin Lee; Seon Young Lee; Weon Sup Lee; Jin San Yoo; Jong-Mu Sun; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Myung-Ju Ahn; Ho Yeong Lim; Won Ki Kang; Young Suk Park
Journal:  Invest New Drugs       Date:  2017-04-08       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.